Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structures of human prostaglandin F2α receptor reveal the mechanism of ligand and G protein selectivity. | Nat Commun | 2023 | 38065938 | PubTator, text mining | PubMed |
| Hyponatremia in patients with arterial hypertension: pathophysiology and management. | Arch Med Sci | 2023 | 38058704 | PubTator, text mining | PubMed |
| Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy. | Biomed Res Int | 2023 | 38058393 | PubTator, text mining | PubMed |
| Docking for EP4R antagonists active against inflammatory pain. | Nat Commun | 2023 | 38057319 | PubTator, text mining | PubMed |
| Structure, function and drug discovery of GPCR signaling. | Mol Biomed | 2023 | 38047990 | PubTator, text mining | PubMed |
| East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease. | Nat Genet | 2023 | 38036781 | PubTator, text mining | PubMed |
| Metabolic influences on T cell in psoriasis: a literature review. | Front Immunol | 2023 | 38035065 | PubTator, text mining | PubMed |
| Gut commensals and their metabolites in health and disease. | Front Microbiol | 2023 | 38029089 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment. | Front Immunol | 2023 | 38022613 | PubTator, text mining | PubMed |
| Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status. | Front Immunol | 2023 | 38022587 | PubTator, text mining | PubMed |
| An encyclopedia of enhancer-gene regulatory interactions in the human genome. | bioRxiv | 2023 | 38014075 | PubTator, text mining | PubMed |
| Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types. | Biomedicines | 2023 | 38002057 | PubTator, text mining | PubMed |
| The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer. | Cancers (Basel) | 2023 | 38001694 | PubTator, text mining | PubMed |
| Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous Ptgs1 induction. | Sci Adv | 2023 | 38000027 | PubTator, text mining | PubMed |
| The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension. | Metabolites | 2023 | 37999248 | PubTator, text mining | PubMed |
| Correction: Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization. | Stem Cell Res Ther | 2023 | 37996940 | PubTator, text mining | PubMed |
| A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer. | Chin J Cancer Res | 2023 | 37969955 | PubTator, text mining | PubMed |
| The role of admixture in the rare variant contribution to inflammatory bowel disease. | Genome Med | 2023 | 37968638 | PubTator, text mining | PubMed |
| Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx. | J Immunother Cancer | 2023 | 37963636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=15